))
Data Governance in the Age of Generative AI with Sebastian Andruszczak
Manage episode 486807905 series 3526489
Content provided by Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Sebastian Andruszczak, Chief Growth Officer at Holisticon (part of the Nexer Group), brings fresh perspective to the conversation around generative AI adoption in pharmaceutical companies. Drawing from his unique background in sales, marketing, and technology, Sebastian cuts through the hype to address fundamental challenges that prevent successful AI implementation in life sciences.
The conversation reveals a critical insight often overlooked in the rush to adopt new technology: without proper data governance, organizations risk "scaling disaster." Sebastian walks us through the specific challenges pharmaceutical companies face - from ever-changing data sources creating inconsistent AI responses, to linguistic variations causing subtle differences in interpretation across global teams. These issues become magnified when implementing AI at enterprise scale, potentially undermining the very efficiencies these technologies promise.
Sebastian outlines a methodical, four-part approach to building effective AI systems: starting with data governance fundamentals, then data engineering, followed by traditional machine learning, and finally generative AI applications. This structured approach has proven successful for companies like Beringer Ingelheim, whose ambitious knowledge management system has already saved one million working hours by processing over 800,000 documents across 200 departments in 70+ countries.
What makes this episode particularly valuable is Sebastian's candid assessment of the industry's current state. While acknowledging the transformative potential of strategic AI initiatives in drug discovery and knowledge management, he challenges the fear-driven implementation happening in many organizations. His "magic wand" wish for the industry reflects this pragmatism: focus first on data quality - a decades-old challenge that finally has the perfect justification for investment.
Whether you're directly involved in pharmaceutical technology implementation or interested in how AI adoption affects life sciences advancement, this episode provides practical insights on building systems that deliver genuine value rather than just following technological trends. Connect with Sebastian on LinkedIn to continue the conversation.
________
Reach out to Ivanna Rosendal
Join the conversation on our LinkedIn page
Chapters
1. Data Governance in the Age of Generative AI with Sebastian Andruszczak (00:00:00)
2. Introduction to Transformation in Trials (00:00:19)
3. Meet Sebastian Andruszak from Holisticon (00:01:33)
4. Understanding Data Governance Fundamentals (00:03:51)
5. Challenges of Generative AI in Pharma (00:06:34)
6. Language Barriers in AI Implementation (00:10:24)
7. Solutions: Building Effective Data Structure (00:17:54)
8. Sebastian's Technology Career Journey (00:23:07)
9. The Future of AI in Life Sciences (00:28:40)
10. Magic Wand: Transforming Data Approach (00:31:57)
78 episodes
Share
